title: Monitoring and diagnosis of cytomegalovirus infection in renal transplantation.
abstract: In this study, the utility of the cytomegalovirus antigen (CMV-AG) and the shell vial (SV) tests in the diagnosis and monitoring of posttransplant CMV infection were compared. Previous retrospective studies from the authors' center suggested that the CMV-AG test, which uses monoclonal antibodies to detect viral antigen in circulating peripheral blood leukocytes (PBL) may be both a more sensitive and specific test. A cohort of 32 renal transplant recipients was followed-up prospectively with serial CMV-AG testing, as well as conventional culture and SV for blood and urine and tests for immunoglobulin M (IgM) antibody. It was discovered that the CMV-AG test was not only more sensitive than the SV test in detecting CMV infection, but that the degree of antigenemia as expressed by the number of positive cells per 50,000 PBL correlated with the likelihood and degree of symptomatic infection. All patients with a count > 10 positive cells/50,000 PBL developed clinical symptoms; therefore, this threshold could be useful in deciding clinically whether fever is related to CMV infection. Alternatively, if antigenemia were monitored serially after transplant, the same threshold could be used as a trigger for instituting antiviral therapy, because it was often reached prior to the onset of symptoms and had a high specificity for subsequent symptomatic infection. Such an approach could obviate unnecessary treatment of patients not destined to become symptomatic. Based upon the findings in this study, the CMV-AG test is superior to the SV assay because the actual count helps determine the likelihood that symptoms are a result of the virus and the processing time is shorter, it can be used to monitor the response to therapy and as a guide to the institution of preemptive therapy.
authors.affiliation: Department of Medicine, State University of New York at Buffalo, USA.
authors.forename: B M
authors.initials: BM
authors.lastname: Murray
authors.forename: D
authors.initials: D
authors.lastname: Amsterdam
authors.forename: V
authors.initials: V
authors.lastname: Gray
authors.forename: J
authors.initials: J
authors.lastname: Myers
authors.forename: J
authors.initials: J
authors.lastname: Gerbasi
authors.forename: R
authors.initials: R
authors.lastname: Venuto
mesh_terms: D000956:Antigens, Viral / Q000032:analysis; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000209:etiology* / Q000503:physiopathology; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D011183:Postoperative Complications; D015995:Prevalence; D011315:Preventive Medicine; D012680:Sensitivity and Specificity
chemical_list: D000956:Antigens, Viral